FDA Inspection 1330852 — Ruffo De Freitas Junior, MD, PhD

Ruffo De Freitas Junior, MD, PhD — FEI 3044684778

The FDA completed an inspection of Ruffo De Freitas Junior, MD, PhD on Jul 24, 2026 in Goiania. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 24, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Goiania (Brazil)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.